Literature DB >> 27694002

Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.

Tong Zhang1, Wei Liu2, Xian-Cheng Zeng3, Nan Jiang4, Bin-Sheng Fu5, Y Guo6, Hui-Ming Yi7, Hua Li8, Qi Zhang9, Wen-Jie Chen10, Gui-Hua Chen11.   

Abstract

miRNAs are involved in substantial biological passways, including tumorigenesis, cancer development and progression. Angiogenesis plays a vital role in the progression of hepatocellular carcinoma (HCC), and VEGF is closely associated with the angiogenesis. However, the molecular mechanism of miRNAs in regulation tumorigenesis of HCC remains to be investigated. In the present research, we confirmed that miR-338-3p was suppressed both in HCC tissues and HCC cell lines. Then the tube formation, transwell and Chorioallantoic membrane (CAM) assay were carried out, such indicated that down-regulation of miR-338-3p can sharply increased, while up-regulation drastically suppressed angiogenesis of HCC cells in vitro. Moreover, MACC1 is predicted to be a target of miR-338-3p and we checked the prediction through luciferase assay. And then, our research showed that negative correlation existed between miR-338-3p and MACC1, β-catenin and VEGF that has been reported participated in cancer behavior in HCC cell lines. Subsequently, our assays illustrated that suppression miR-338-3p can up-regulate MACC1, β-catenin and VEGF expression of HCC cells. In conclusion, our research discovered that miR-338-3p can contribute to HCC angiogenesis by targeting MACC1, β-catenin and VEGF.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Angiogenesis; Hepatocellular carcinoma; VEGF; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27694002     DOI: 10.1016/j.biopha.2016.09.056

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity.

Authors:  Fuqiang Jin; Jie Xing
Journal:  Neurol Sci       Date:  2017-09-05       Impact factor: 3.307

2.  Long non-coding RNA DSCAM-AS1 accelerates the progression of hepatocellular carcinoma via sponging miR-338-3p.

Authors:  Degang Ji; Guangrui Hu; Xuanhe Zhang; Tianhua Yu; Jinghui Yang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 3.  Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.

Authors:  Vikrant Rai; Joe Abdo; Abdullah N Alsuwaidan; Swati Agrawal; Poonam Sharma; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-06-07       Impact factor: 3.842

Review 4.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

5.  miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting UROC28 in hepatoma cells.

Authors:  Qinglei Kong; Jianhua Han; Hong Deng; Feilong Wu; Shaozhong Guo; Zhiqiang Ye
Journal:  Onco Targets Ther       Date:  2018-10-04       Impact factor: 4.147

Review 6.  Angiogenesis-related non-coding RNAs and gastrointestinal cancer.

Authors:  Zahra Sadat Razavi; Kasra Asgarpour; Maryam Mahjoubin-Tehran; Susan Rasouli; Haroon Khan; Mohammad Karim Shahrzad; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-05-15       Impact factor: 7.200

7.  Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change.

Authors:  Hai Yu; Jian Zheng; Xiaobai Liu; Yixue Xue; Shuyuan Shen; Lini Zhao; Zhen Li; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2017-09-21       Impact factor: 5.639

8.  The tumor suppressor role of microRNA-338-3p in renal cell carcinoma.

Authors:  Yidong Huang; Yang Wu; Li Zeng; Wei Shan; Lugang Huang
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

9.  miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5.

Authors:  Xiaoqian Zhang; Chunxia Wang; Hui Li; Xiaobin Niu; Xinwei Liu; Dongxu Pei; Xiaolan Guo; Xiaona Xu; Yongwei Li
Journal:  Oncotarget       Date:  2017-07-18

10.  lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway.

Authors:  Qi Zhang; Tianfu Li; Zhecun Wang; Xiaying Kuang; Nan Shao; Ying Lin
Journal:  J Cell Mol Med       Date:  2020-06-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.